• On September 25, 2025, Redwire Corporation announced it had been awarded a contract by Axiom Space to deliver roll-out solar array wings for the AxPPTM module, marking a key step in the assembly of the first commercial space station post-International Space Station era.
• This contract underscores Redwire's critical role in shaping the next generation of commercial space infrastructure and highlights the company's technology being tapped for sustained U.S. human presence in low-Earth orbit.
• We'll examine how Redwire's solar array contract for Axiom's commercial space station supports its position in orbital infrastructure expansion.

We've found 19 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

Redwire Investment Narrative Recap

To own Redwire stock, you need to believe in the company's ability to convert commercial space infrastructure wins, like the recent Axiom Space contract, into meaningful revenue growth, while managing the risks of cost overruns on complex projects. This news adds credibility to Redwire’s technology and supports optimism around the expanding low-Earth orbit market; however, the immediate impact on the company’s biggest short-term risk, earnings visibility and margin volatility tied to long-term fixed price contracts, appears limited for now.

Among Redwire’s recent announcements, the $25 million NASA biotechnology facility contract stands out, highlighting both contract diversification and exposure to promising high-margin biotech services. This aligns with near-term catalysts focused on recurring revenue streams and product portfolio expansion, even as the Axiom win continues to build long-term infrastructure credibility for Redwire. Contrast that with growing concerns around the unpredictability and exposure of large fixed-price contracts, especially as...

Redwire's narrative projects $887.3 million revenue and $73.2 million earnings by 2028. This requires 50.3% yearly revenue growth and a $322.7 million earnings increase from -$249.5 million.

Uncover how Redwire's forecasts yield a $18.06 fair value, a 74% upside to its current price.

Exploring Other Perspectives

Fair value estimates from 10 Simply Wall St Community members range from US$17.24 to US$40.80 per share, illustrating broad opinion on Redwire’s prospects. With ongoing dependence on large, complex contracts, it’s clear that individual investor views about future stability and growth potential can vary widely.

Explore 10 other fair value estimates on Redwire - why the stock might be worth just $17.24!

Build Your Own Redwire Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Redwire research is our analysis highlighting 2 key rewards and 4 important warning signs that could impact your investment decision.
• Our free Redwire research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Redwire's overall financial health at a glance.

Looking For Alternative Opportunities?

Our daily scans reveal stocks with breakout potential. Don't miss this chance:

• Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 32 best rare earth metal stocks of the very few that mine this essential strategic resource.
• The end of cancer? These 28 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
• AI is about to change healthcare. These 31 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.